Anales RANF

Juan Aparicio Blanco, Ignacio A. Romero, Jean P Benoit, Ana I. Torres Suárez @Real Academia Nacional de Farmacia. Spain 214 Supporting information Figure S1: Zeta potential profiles for blank LNCs (a: smaller-sized formulation and d: bigger-sized formulation), CBD-decorated LNCs (b: smaller-sized formulation and e: bigger-sized formulation) and CBD-encapsulated LNCs (c: smaller-sized formulation and f: bigger-sized formulation). Table S1: CBD adsorption/encapsulation efficiencies (AE/EE) and drug content (DC) of the different LNCs discussed in the manuscript. LNC formulation AE/EE (%) DC (%) Smaller-sized CBD-adsorbed LNCs 96.99 ± 2.58 1.55 ± 0.07 Bigger-sized CBD-adsorbed LNCs 95.97 ± 4.72 2.17 ± 0.06 Smaller-sized CBD-encapsulated LNCs 96.75 ± 1.45 4.30 ± 0.07 Bigger-sized CBD-encapsulated LNCs 96.43 ± 3.25 7.66 ± 0.30